Peter Hsi

Title: Innovations by Peter Hsi in Electroporation Technology

Introduction

Peter Hsi is an accomplished inventor based in Waltham, MA (US). He has made significant contributions to the field of biotechnology, particularly in the area of electroporation. His innovative work focuses on enhancing the delivery of genetic materials to cells, which has important implications for medical and research applications.

Latest Patents

Peter Hsi holds a patent for a "Method and apparatus for electroporation of acoustically-aligned cells." This patent describes a hands-free, automated, and continuous process for transferring genetic and other materials to cells. The method involves flowing cells between electroporation electrodes to facilitate the delivery of a payload into the cells while acoustophoretically focusing the cells. Additionally, the patent outlines a control method for the acoustophoretic focusing of cells, which includes detecting the locations of cells flowing through a channel using an image analytics system. The system modulates a drive signal to an acoustic transducer to adjust the locations of the cells. Furthermore, an electroporation driver module is detailed, which utilizes a digital to analog converter to generate an electroporation waveform and an amplifier to enhance the waveform for application to the electroporation electrodes.

Career Highlights

Peter Hsi is currently employed at the Charles Stark Draper Laboratory, Inc., where he continues to develop innovative technologies. His work has positioned him as a key figure in the advancement of electroporation techniques, contributing to the efficiency and effectiveness of genetic material delivery.

Collaborations

Peter collaborates with notable colleagues, including Vishal Tandon and Charles A. Lissandrello. Their combined expertise fosters a dynamic environment for innovation and research.

Conclusion

Peter Hsi's contributions to electroporation technology exemplify the intersection of innovation and biotechnology. His patented methods enhance the capabilities of genetic material delivery, paving the way for advancements in medical research and applications.